农村和城市1型糖尿病患者的区别-A试点研究
Beata I Sińska1, Alicja Kucharska1, Ewa Rzońca2
1Department of Human Nutrition, Faculty of Health Sciences, Medical University of Warsaw, 01-445 Warsaw, Poland.
Nutrients
|January 11, 2024
概括
与城市居民相比,生活在农村地区的1型糖尿病患者的健康状况较差,治疗遵守率较低. 需要有针对性的干预措施来改善农村社区糖尿病管理.
科学领域:
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
- 心理学 心理学 心理学
背景情况:
- 有效的糖尿病管理受到各种患者依赖和独立因素的影响.
- 居住地是糖尿病健康结果和治疗坚持的潜在决定因素.
- 了解这些差异对于制定有针对性的健康战略至关重要.
研究的目的:
- 分析1型糖尿病 (T1D) 的成年人居住地 (农村与城市) 与社会人口统计学,心理和糖尿病相关参数之间的关系.
- 确定农村和城市T1D人口之间的健康状况和自我管理的差异.
主要方法:
- 一项涉及419名患有T1D的成年人的研究,使用非概率抽样.
- 利用调查问卷评估饮食坚持,接受疾病,健康责任,饮食行为以及社会人口统计学/糖尿病相关因素.
- 居住在农村和城市地区的个人之间的参数比较.
主要成果:
- 患有T1D的农村居民比城市居民年轻,受教育程度较低,体重较高,HbA1c水平较高,血糖测量频率较低,并且报告疾病接受率较高.
- 城市居民显著更好地遵守饮食建议,并对自己的健康负有更强的责任感.
- 在基于地理位置的关键糖尿病管理指标中观察到显著差异.
结论:
- 居住地与1型糖尿病的健康状况和管理的显著差异有关.
- 农村社区正确饮食和有效疾病管理的障碍需要评估和干预.
- 制定有针对性的健康促进策略,特别是针对农村T1D患者,对于改善健康结果至关重要.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Insulin: Dosing Regimen and Adverse Effects
175
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
175
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Diabetes: Symptoms, Diagnosis, and Complications
546
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
546
Diabetes: Management and Pharmacotherapy
285
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
285
Insulin Formulations: Types and Delivery
197
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
197


